Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
8 studies found for:    Boeckh
Show Display Options
Rank Status Study
1 Completed
Has Results
TCAD vs. Monotherapy for Influenza A in Immunocompromised Patients
Condition: Influenza
Interventions: Drug: TCAD;   Drug: Zanamivir or Oseltamivir;   Other: Open label treatment with TCAD
2 Completed Long-Term Oral Acyclovir Usage to Prevent Herpes Zoster Virus Infection After Bone Marrow Transplant
Condition: VZV Infection After Bone Marrow Transplantation
Intervention: Drug: Acyclovir
3 Completed Ribavirin Compared With Standard Care in Treating Patients With Respiratory Syncytial Virus Following Stem Cell Transplantation
Condition: Infection
Intervention: Drug: ribavirin
4 Completed Valganciclovir to Prevent Cytomegalovirus Infection in Patients Following Donor Stem Cell Transplantation
Condition: Infection
Interventions: Drug: ganciclovir;   Drug: valganciclovir
5 Completed Ribavirin With or Without Monoclonal Antibody Therapy in Treating Patients Who Develop RSV Pneumonia Following Peripheral Stem Cell Transplantation
Condition: Cancer
Interventions: Biological: palivizumab;   Drug: ribavirin
6 Active, not recruiting Study of Ganciclovir/Valganciclovir for Prevention of Cytomegalovirus Reactivation in Acute Injury of the Lung and Respiratory Failure
Conditions: Acute Lung Injury;   Acute Respiratory Distress Syndrome;   Respiratory Failure
Interventions: Drug: IV Ganciclovir;   Drug: Placebo
7 Recruiting Integrated Collaborative Care Teams for Youth With Mental Health and/or Addiction Challenges (YouthCan IMPACT)
Conditions: Mental Disorders;   Addiction
Interventions: Behavioral: Integrated Collaborative Care Team (ICCT);   Other: Treatment as Usual (TAU)
8 Recruiting The Chimerix CMX001 Registry
Conditions: Outcomes;   Survival Rates
Intervention: Drug: CMX001

Study has passed its completion date and status has not been verified in more than two years.